Yixi Chen

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model.

Estimating the value of new antibiotic treatment strategies in Zhejiang province, China: cost-effectiveness analysis based on a validated dynamic model.

Journal: BMJ open

Published: August 29, 2024

Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach.

Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach.

Journal: Journal of market access & health policy

Published: June 19, 2024

Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China.

Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China.

Journal: PharmacoEconomics

Published: August 31, 2020

Machine Learning for Precision Health Economics and Outcomes Research (P-HEOR): Conceptual Review of Applications and Next Steps.

Machine Learning for Precision Health Economics and Outcomes Research (P-HEOR): Conceptual Review of Applications and Next Steps.

Journal: Journal of health economics and outcomes research

Published: October 07, 2019

Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China.

Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China.

Journal: PloS one

Published: October 20, 2016

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value.

Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to Value.

Journal: Journal of personalized medicine

Published: August 25, 2016

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China.

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: July 02, 2016

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China.

Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People's Republic of China.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: April 13, 2016

Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform.

Drug pricing reform in China: analysis of piloted approaches and potential impact of the reform.

Journal: Journal of market access & health policy

Published: November 19, 2015

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital.

Linezolid for the treatment of hospital-acquired pneumonia in a Chinese tertiary hospital.

Journal: ClinicoEconomics and outcomes research : CEOR

Published: November 12, 2015

Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in China.

Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in China.

Journal: Value in health regional issues

Published: May 01, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026